ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
47 hedge funds and large institutions have $11.8M invested in Acorda Therapeutics in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
59% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 22
Holders
47
Holding in Top 10
–
Calls
$226K
Puts
$102K
Top Buyers
1 | +$171K | |
2 | +$149K | |
3 | +$134K | |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$103K |
5 |
![]()
Group One Trading
Chicago,
Illinois
|
+$81K |
Top Sellers
1 | -$829K | |
2 | -$756K | |
3 | -$719K | |
4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$346K |
5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$222K |